The aim of the screening project is to develop a roadmap for a national screening program for the early detection and treatment of cardiovascular disease, chronic kidney disease and type 2 diabetes.

The screening project is an initiative of the Dutch Cardiovascular Alliance (DCVA) and is funded by a grant of the Dutch Research Council (NWO), and financial contributions from the Dutch Heart Foundation, the Dutch Kidney Foundation, the Dutch Diabetes Research Foundation, and various private partners, including Roche Diagnostics, AstraZeneca, Siemens Healthineers, Topicus, and Happitech.

The screening project will be enrolled in different phases across four regions in the Netherlands (Breda, Utrecht, Arnhem, Eindhoven). The aim is to invite the first participants from the Breda region in early 2025.

Three different home-based tests will be used in the first phase of the screening project:

• The CE-certified PeeSpot urine collection device will be used to collect urine of participants. After urine collection, the PeeSpot is mailed to the laboratory for measuring albuminuria (albumin-to-creatinine ratio), an early marker of chronic kidney disease.
• Atrial fibrillation can be measured using the CE-certified Happitech software. This software relies on photoplethysmographic signals to assess heart rhythm.
• A subset of participants will receive a questionnaire that includes the RED-CVD tool, designed to identify individuals with atrial fibrillation, coronary artery disease, and heart failure, as well as questions aimed at the early detection of type 2 diabetes and questions evaluating the participants' health literacy.

In later phases of the screening project, other home-based screening tests might be evaluated.

Currently 1.55 million, 2 million, and 1.2 million people in the Netherlands are affected by cardiovascular diseases, chronic kidney disease and type 2 diabetes. The numbers of people suffering from chronic diseases is expected to grow in the coming year in the Netherlands. In addition, a lot of people are unaware having these chronic diseases, as it is often present without overt symptoms. To overcome these problems, the screening project is established to develop a roadmap for early detection of these chronic diseases.

You can fill in the contact form via 'contact' or send an email to info@checkathome.nl.

Please contact us via info@checkathome.nl to discuss the opportunities.

The Check@Home consortium is an initiative of the Dutch CardioVascular Alliance (DCVA), the Dutch Heart Foundation, the Dutch Kidney Foundation, and the Dutch Diabetes Research Foundation. Various parties are collaborating within the consortium, including industrial partners, medical experts, and researchers and specialists in social sciences, health economics, and communication from several Dutch university medical centers, universities and regional hospitals. An overview of all consortium partners and collaborating partners can be found here.